What is the half-life of lorazepam (Ativan) and how long does it take to be completely eliminated from the system for a drug test?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: October 20, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Lorazepam Half-Life and Detection Time for Drug Testing

Lorazepam has an elimination half-life of approximately 12 hours in adults and typically requires 5-6 half-lives (60-72 hours) to be completely eliminated from the body for drug testing purposes. 1, 2

Pharmacokinetic Properties of Lorazepam

  • Lorazepam has a mean half-life of approximately 12 hours for the unconjugated form in human plasma 1
  • The half-life of its major metabolite, lorazepam glucuronide, is about 18 hours 1
  • Peak plasma concentrations occur approximately 2 hours following oral administration 1, 3
  • At clinically relevant concentrations, lorazepam is approximately 85% bound to plasma proteins 1
  • Lorazepam is rapidly conjugated at its 3-hydroxy group into lorazepam glucuronide, which is then excreted in the urine 1, 2
  • The glucuronide metabolite has no demonstrable central nervous system activity 1

Detection Window for Drug Testing

  • Complete elimination of lorazepam and its glucuronide conjugate typically occurs within 1 week following the last dose 2
  • For standard drug tests, detection times vary based on:
    • Dosage administered 1
    • Duration of use (acute vs. chronic) 2
    • Individual factors (age, liver/kidney function) 4
    • Type of drug test used (urine, blood, hair) 2

Factors Affecting Elimination Time

  • Age: Studies comparing young and elderly subjects have shown that advancing age does not significantly affect lorazepam pharmacokinetics, though some studies show clearance decreased by 20% in elderly subjects 1
  • Liver function: Lorazepam is primarily metabolized through glucuronidation in the liver, so liver impairment may extend detection time 4
  • Kidney function: Since lorazepam glucuronide is excreted through the kidneys, renal impairment can extend detection time 4
  • Chronic use: There is no evidence of accumulation of lorazepam on administration up to 6 months 1, but regular use may lead to longer detection windows

Detection Times by Sample Type

  • Urine: Typically detectable for 3-7 days after last use 2
  • Blood: Usually detectable for 1-4 days 3
  • Hair: May be detectable for weeks to months, depending on hair length and test sensitivity 2

Clinical Considerations

  • Lorazepam does not produce active metabolites that might extend psychoactive effects beyond its half-life 1, 4
  • 70-75% of the administered dose is excreted as the glucuronide conjugate in the urine 2
  • On multiple-dose regimens, steady-state blood levels directly proportional to the daily dose occur within 2-3 days 2

Common Pitfalls in Drug Testing Interpretation

  • False positives can occur with some immunoassay tests for benzodiazepines 2
  • Confirmatory testing using gas chromatography-mass spectrometry (GC-MS) or liquid chromatography-mass spectrometry (LC-MS) provides more accurate results 2
  • Different benzodiazepines have varying detection windows - lorazepam's half-life (12 hours) is intermediate compared to short-acting benzodiazepines like midazolam (2.9-4.5 hours) and longer-acting ones like diazepam (up to 50 hours) 5

References

Research

Clinical pharmacokinetics of lorazepam: a review.

The Journal of clinical psychiatry, 1978

Research

Clinical pharmacokinetics of oxazepam and lorazepam.

Clinical pharmacokinetics, 1981

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.